Back
Amicus Therapeutics Stock Price Chart
Sponsored
FOLD
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
44
FOLD
Amicus Therapeutics
Last Price:
10.10
Seasonality Move:
8.32%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.98 | Sell |
20-day SMA: | 11.32 | Sell |
50-day SMA: | 11.06 | Sell |
200-day SMA: | 11.08 | Sell |
8-day EMA: | 10.86 | Sell |
20-day EMA: | 11.06 | Sell |
50-day EMA: | 11.04 | Sell |
200-day EMA: | 11.1 | Sell |
Amicus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 36.89 | Sell |
Chaikin Money Flow: | -1470064 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.52 - 11.72) | Sell |
Bollinger Bands (100): | (10.2 - 11.54) | Sell |
Amicus Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.38 while FOLD 8-day simple moving average is 10.98, which is a Sell signal.
- The stock price of FOLD is 10.38 while Amicus Therapeutics 20-day SMA is 11.32, which makes it a Sell.
- Amicus Therapeutics 50-day simple moving average is 11.06 while FOLD share price is 10.38, making it a Sell technically.
- FOLD stock price is 10.38 and Amicus Therapeutics 200-day simple moving average is 11.08, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $10.38. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.1B
Price in USD:
10.38
Share Volume:
2.65M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 10.38 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 10.38 while FOLD 8-day exponential moving average is 10.86, which is a Sell signal.
- The stock price of FOLD is 10.38 while Amicus Therapeutics 20-day EMA is 11.06, which makes it a Sell.
- Amicus Therapeutics 50-day exponential moving average is 11.04 while FOLD share price is 10.38, making it a Sell technically.
- FOLD stock price is 10.38 and Amicus Therapeutics 200-day simple moving average is 11.10, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Amicus Therapeutics is a Sell
- Amicus Therapeutics Relative Strength Index (RSI) is 36.89, which suggest Amicus Therapeutics is oversold
- The Bollinger Bands (25) for Amicus Therapeutics is (10.52 - 11.72), which suggest Amicus Therapeutics is a Sell
- The Bollinger Bands (100) for Amicus Therapeutics is (10.2 - 11.54), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.